iLite® EGFR (-) Target
BM5036
A negative control cell line for EGFR-targeted bioassays, this iLite® target is used in assay specificity evaluation.
- "Assay-ready" format for rapid and convenient use
- Reproducible and biologically relevant results
- Reduced assay variability and higher reproducibility compared to cells in culture
Product Overview
iLite® ADCC Target EGFR (-) Assay Ready Cells are based on the human embryonic kidney cell line, HEK293, and have been genetically engineered to be depleted of EGRF expression.
These cells are optimized to be used as negative control together with iLite® ADCC Effector (V) Assay Ready Cells and iLite® ADCC Target EGFR (+) Assay Ready Cells for measuring the ADCC activity of anti-EGFR antibodies.
FOR RESEARCH USE ONLY
How it works
Principle of iLite® ADCC Bioassays
Our two-cell ADCC bioassays consist of target cells expressing the antigen under study and effector cells closely resembling the natural FcγRIIIa (CD16) signal transduction pathway. Target control cells that do not express the antigen are also available. The effector cells contain two luciferase genes: an inducible Firefly luciferase gene and a constitutively expressed Renilla luciferase gene used for control purposes.
What's in the box?
>250 µL of Assay Ready Cells suspended in cryoprotective medium from Gibco (cat no 12648-010).
Specifications
| Product code | BM5036 |
| Assay target | ADCC EGFR |
| Size | 1 vial corresponding to one 96 well plate |
| Technology | Cell-based reporter gene assay |
| Detection system | Luminescence |
| Regulatory status | Research Use Only |
